Skip to main content

MJFF in the News

Read current and past news articles about The Michael J. Fox Foundation.

  • The Hill Logo

    The Hill, "EPA to Make Regulatory Decisions Using Questionable Science"

    MJFF CEO writes Op-ed in "The Hill" to advocate for the Parkinson's community on a proposed rule by the EPA that would limit the amount of types of science used in determining federal regulations, including policies and programs related to environmental restrictions in support of health.

  • BBC News logo

    BBC News "The Truth about Parkinson's"

    MJFF CEO and other Parkinson’s disease (PD) experts — people living with the disease and scientists from around the world — participated in a three-episode radio series on "The Truth about Parkinson's" on the BBC.

  • Logo for Fortune.

    Fortune, “Exclusive: Billionaire Ken Griffin to Fund $10 Million Parkinson’s Competition with Michael J. Fox Foundation”

    Ken Griffin, Founder and CEO of the Chicago-based global investment firm Citadel and MJFF Co-Founder Debi Brooks spoke with Fortune’s Sy Mukherjee on the $10-million program spurring a scientific race in pursuit of a game-changing tool in Parkinson’s research.  

  • Logo for Fortune.

    Fortune, "World's Greatest Leaders"

    Fortune Magazine released their sixth annual list of the "World's Greatest Leaders" with Michael J. Fox listed at 22 for his leadership with the Foundation and our work to end Parkinson's disease.

  • Logo for Fortune.

    Fortune, "Michael J. Fox on Living with Parkinson's, Research Challenges, and His New Tattoo"

    Michael J. Fox and Debi Brooks chat with Fortune about how patients are driving research forward.

  • Logo for New York Times Magazine.

    New York Times Magazine, "Michael J. Fox on acting with Parkinson's, taking the wrong roles and staying positive: 'Until it’s not funny anymore, it is funny.'"

    Michael J. Fox sat down for an intimate Q&A with the New York Times Magazine’s Talk column.

  • Bloomberg logo

    Bloomberg, "The Michael J. Fox Foundation Gets Results"

    The column discusses the Foundation's "de-risking" strategy and impact, using the recent FDA approval of Inbrija as a proof point on the current transformation in Parkinson's research.

  • Forbes logo

    Forbes, "Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J. Fox"

    Timed during the 12th annual Parkinson's Disease Therapeutics Conference, "Forbes" covered a historical moment for the promising genetic target LRRK2 and the Foundation's role in moving research forward.

Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.